ImmuCell
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $5,506 | $6,444 | $8,067 | $7,751 |
Gross Profit | 2,363 | 2,817 | 3,353 | 2,831 |
EBITDA | 543 | 1,296 | 1,793 | 1,319 |
EBIT | -135 | 628 | 1,117 | 645 |
Net Income | -139 | 501 | 1,446 | 514 |
Net Change In Cash | 5,506 | 6,444 | 8,067 | 7,751 |
Free Cash Flow | -1,776 | 1,446 | 1,244 | -199 |
Cash | 3,886 | 5,998 | 4,599 | 3,758 |
Basic Shares | 9,046 | 9,031 | 8,980 | 8,935 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $26,493 | $17,471 | $18,568 | $19,242 |
Gross Profit | 7,941 | 4,396 | 7,649 | 8,655 |
EBITDA | 1,066 | -2,504 | 188 | 2,698 |
EBIT | -1,620 | -5,221 | -2,299 | 237 |
Net Income | -2,156 | -5,774 | -2,494 | -78 |
Net Change In Cash | 26,493 | 17,471 | 18,568 | 19,242 |
Free Cash Flow | -107 | -6,566 | -5,519 | -1,654 |
Cash | 3,758 | 978 | 5,792 | 10,185 |
Basic Shares | 8,167 | 7,747 | 7,745 | 7,592 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.02 |
2025-06-30 | $0.06 |
2025-03-31 | $0.16 |
2024-12-31 | $0.05 |
